National Toxicology Program Requests Data on 11 Chemicals

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 7
Volume 7
Issue 7

RESEARCH TRIANGLE PARK, NC--The National Toxicology Program has requested public input on 11 chemicals recommended for absorption, toxicity, or carcinogenicity studies. It seeks information from completed or ongoing studies, and information on planned studies, as well as current production data, human exposure information, use patterns, and environmental occurrences.

RESEARCH TRIANGLE PARK, NC--The National Toxicology Program has requested public input on 11 chemicals recommended for absorption, toxicity, or carcinogenicity studies. It seeks information from completed or ongoing studies, and information on planned studies, as well as current production data, human exposure information, use patterns, and environmental occurrences.

The compounds include bixin and fenchone, natural products with widespread human exposure; diethylamine, found in some foods; dihydroxyacetone, a component of tanning compounds; isopropylamine, a natural product in foods; pulegone, a flavoring; menthofu-ran, a metabolite of pulegone; and alpha-solanine, a known human toxicant.

Also, alpha-thujone a component of food flavoring additives; triethylamine, a workplace contaminant, and trigonelline, a plant hormone with widespread human exposure through diet.

Information may be submitted until July 27 to William Eastin, NIEHS/NTP, P.O. Box 12233, Research Triangle Park, NC 27709; Fax: 919-541-3687; e-mail: Eastin@NIEHS.

Recent Videos
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
Related Content